Spanish pharmaceutical group Esteve has appointed Albert Esteve as its chairman of the board of directors to replace Joan Esteve, who will continue serving the group as chairman of the general shareholders meeting.
Albert Esteve joined the group as an assistant to general management and was appointed member of the group’s executive committee and has been chief executive officer since 2011.
Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive vice president and chief commercial officer.
Esteve said: “This is a new challenge that I am facing with tremendous enthusiasm.
“Regarding the CEO appointment, we feel fortunate and are much honoured to welcome Staffan Schuberg as the new executive leader of the group.”